No Data
No Data
Express News | Carl L. Gordon Reports 9.99% Stake in Chemomab Therapeutics as of Sept 12 Vs 16.0% as Reported in March 11 - SEC Filing
ADRs Close Lower; Chemomab Therapeutics Ltd. Declines 17%
Express News | Chemomab Therapeutics Ltd Files for Resale of up to 8.1 Mln Adss by the Selling Shareholders - SEC Filing
Chemomab Therapeutics (CMMB) Gets a Buy From Oppenheimer
Express News | Chemomab Says Existing Liquidity Resources Of $12.8M As Of June 30, 2024, Together With The Additional Funds Of Approximately $10M Raised In July 2024, Will Enable The Company To Fund Its Operations Through The Beginning Of 2026
Express News | Chemomab Therapeutics Q2 2024 GAAP EPS $(0.01), Inline
No Data
No Data